Ixazomib-based consolidation and maintenance prolongs progression-free survival after salvage autologous stem cell transplantation (sASCT): Results from interim analysis of UK-MRA myeloma XII (ACCoRD)

Cook, G., Ashcroft, A.J., Senior, E.R. et al. (16 more authors) (2023) Ixazomib-based consolidation and maintenance prolongs progression-free survival after salvage autologous stem cell transplantation (sASCT): Results from interim analysis of UK-MRA myeloma XII (ACCoRD). In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 783.

Metadata

Authors/Creators:
  • Cook, G.
  • Ashcroft, A.J.
  • Senior, E.R.
  • Olivier, C.
  • Hockaday, A.
  • Richards, J.
  • Cavenagh, J.D.
  • Snowden, J. ORCID logo https://orcid.org/0000-0001-6819-3476
  • Drayson, M.
  • de Tute, R.M.
  • Owen, R.
  • Yong, K.
  • Garg, M.
  • Boyd, K.
  • Sati, H.
  • Gillson, S.
  • Cook, M.
  • Cairns, D.A.
  • Parrish, C.
Copyright, Publisher and Additional Information: © 2023 by The American Society of Hematology.
Keywords: Biomedical and Clinical Sciences; Cardiovascular Medicine and Haematology; Oncology and Carcinogenesis; Cancer; Rare Diseases; Clinical Research; Hematology; Clinical Trials and Supportive Activities; Pharmaceuticals; Evaluation of treatments and therapeutic interventions; Cancer
Dates:
  • Published (online): 28 November 2023
  • Published: 2 November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 13 Dec 2023 11:33
Last Modified: 13 Dec 2023 12:29
Status: Published
Publisher: American Society of Hematology
Refereed: Yes
Identification Number: https://doi.org/10.1182/blood-2023-188532

Export

Statistics